In TB, an 8-wk, 5-drug regimen was noninferior to a standard 24-wk, 4-drug regimen for clinical outcomes at 96 wk.
Where this comes from
- Record sourced from PubMed, PMID 37276602.
- Also identified by DOI 10.7326/J23-0036.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Paton NI, Cousins C, Suresh C, et al; TRUNCATE-TB Trial Team. <b>Treatment strategy for rifampin-susceptible tuberculosis.</b> N Engl J Med. 2023;388:873-887. 36808186.
Medical subject headings
- Antitubercular Agents
- Tuberculosis